fruit of the loom posts

Feed

Crocs, Berkshire Hathaway license Marvel's superhero characters

Warren Buffet has joined the Crocs Inc. (NASDAQ: CROX) craze, at least parenthetically. Fruit of the Loom, owned by Berkshire Hathaway (NYSE:BRK.A), has joined Crocs in licensing the right to use Marvel Entertainment Inc.'s (NYSE: MVL) superheros on their products.

For Crocs, this builds on an already impressive array of tie-in arrangements, including the Time Warner (NYSE:TWX) deal Jon Ogg blogged about here last week, in which they gained the right to Looney Tunes, Hanna-Barbera and Scooby-Doo characters from the Warner Brother's closet.

Among the figures in the Marvel Universe are Spiderman, the X-Men, the Fantastic Four, and the Hulk. The Hulk will be featured in one of next summer's blockbuster-wannabes, The Incredible Hulk.

Fruit of the Loom offers character underwear featuring icons such as Batman, Scooby-Doo (they missed a bet here, not naming this line Scooby-Doo-Doo), and (appropriately enough) Nickelodeon's SpongeBob SquarePants.

See our Crocs gallery for more about the fashionable footwear.

Berkshire Hathaway earnings -- who knows?

From its origin in textiles in the nineteenth century, Berkshire Hathaway (NYSE:BRK.A) has grown to become the monster holding company that it is today. Though its core business is now insurance, BRK has fingers in many pies: from owning Geico, Dairy Queen and Fruit of the Loom, to its pieces in the Washington Post Co. (NYSE:WPO), UPS Inc. (NYSE:UPS), and Target Corp. (NYSE:TGT), among many others.

It's all led by investment sage Warren Buffett, the so-called Oracle of Omaha. Buffett is well-known for his philosophy of value investing for the long run, and has often discouraged focusing on quarterly reports. That may be why I had such a hard time finding a confirmed release date for BRK's next earnings report. It also may be why so few analysts closely cover BRK, even though multitudes of individual investors hang on Buffett's every word and move.

The consensus estimate, to the extent that one can truly reach a consensus with only two or three analysts' opinions, is for $1452.36 per share, or growth of 21.4%, according to Thomson Financial. As diversified as BRK is, it's hard to imagine it having a weak quarter, yet BRK.A is rated as a hold by analysts, for reasons our own Jonathon Berr recently explored. The median target price is $123,000. BRK class A shares closed Wednesday at $110,050 (class B shares at $3,667).

That may be neither here nor there for investors, who, like Buffett, are in it for the long haul. BRK will report sometime between now and March 1, and when it does, will it beat the expectations of those who suggest holding (or even selling) the stock, few as they may be? Or will analysts be right and BRK will somehow fall short? What do you think?

Also check out some other earnings reports that we're following, and let us know what you're expecting.

Symbol Lookup
IndexesChangePrice
DJIA-74.9212,454.83
NASDAQ-1.852,837.53
S&P 500-2.861,317.82

Last updated: May 28, 2012: 02:59 PM

Hot Stocks

General Electric

19.20-0.05(-0.26)

Alcoa

8.630.00(0.00)

Apple Inc

562.29-3.03(-0.54)

Google Inc 'A'

591.53-12.13(-2.01)

Bank of America

7.15+0.01(+0.14)

Wal-Mart Stores

65.31+0.24(+0.37)

Exxon Mobil Corp

82.08-0.53(-0.64)

Ford

10.60+0.01(+0.09)

Citigroup

26.47-0.19(-0.71)

IBM

194.30-1.79(-0.91)

Yahoo

15.36+0.01(+0.07)

Starbucks

54.56-0.20(-0.37)

Microsoft

29.06-0.01(-0.03)

Home Depot

49.44-0.27(-0.54)

DailyFinance Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

Page Loaded in 1338231586035 ms.